JPWO2022178367A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022178367A5
JPWO2022178367A5 JP2023551146A JP2023551146A JPWO2022178367A5 JP WO2022178367 A5 JPWO2022178367 A5 JP WO2022178367A5 JP 2023551146 A JP2023551146 A JP 2023551146A JP 2023551146 A JP2023551146 A JP 2023551146A JP WO2022178367 A5 JPWO2022178367 A5 JP WO2022178367A5
Authority
JP
Japan
Prior art keywords
domain
cell
antigen
receptor
sar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023551146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518011A (ja
JP2024518011A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017177 external-priority patent/WO2022178367A2/en
Publication of JP2024518011A publication Critical patent/JP2024518011A/ja
Publication of JPWO2022178367A5 publication Critical patent/JPWO2022178367A5/ja
Publication of JP2024518011A5 publication Critical patent/JP2024518011A5/ja
Pending legal-status Critical Current

Links

JP2023551146A 2021-02-19 2022-02-21 多様な免疫細胞のための単鎖および多鎖合成抗原受容体 Pending JP2024518011A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163151421P 2021-02-19 2021-02-19
US63/151,421 2021-02-19
US202163245181P 2021-09-16 2021-09-16
US63/245,181 2021-09-16
PCT/US2022/017177 WO2022178367A2 (en) 2021-02-19 2022-02-21 Single-chain and multi-chain synthetic antigen receptors for diverse immune cells

Publications (3)

Publication Number Publication Date
JP2024518011A JP2024518011A (ja) 2024-04-24
JPWO2022178367A5 true JPWO2022178367A5 (https=) 2025-04-10
JP2024518011A5 JP2024518011A5 (https=) 2025-04-10

Family

ID=82932320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551146A Pending JP2024518011A (ja) 2021-02-19 2022-02-21 多様な免疫細胞のための単鎖および多鎖合成抗原受容体

Country Status (8)

Country Link
US (1) US20240390496A1 (https=)
EP (1) EP4297769A4 (https=)
JP (1) JP2024518011A (https=)
KR (1) KR20230153529A (https=)
AU (1) AU2022224066A1 (https=)
CA (1) CA3208717A1 (https=)
IL (1) IL305175A (https=)
WO (1) WO2022178367A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202000025SA (en) 2017-07-14 2020-02-27 Immatics Biotechnologies Gmbh Improved dual specificity polypeptide molecule
AU2018308088B2 (en) 2017-07-25 2025-05-29 Truebinding, Inc. Treating cancer by blocking the interaction of TIM-3 and its ligand
MX2020012927A (es) * 2018-06-01 2021-03-25 Univ Southern California Diversos dominios de enlace de antigenos, nuevas plataformas y otras mejoras para terapia celular.
AU2020214796A1 (en) 2019-01-30 2021-07-29 Truebinding, Inc. Anti-Gal3 antibodies and uses thereof
CA3174575A1 (en) 2020-03-02 2021-09-10 The Regents Of The University Of California Chimeric antigen receptors and related methods and compositions for the treatment of cancer
WO2021242776A2 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3
EP4334361A1 (en) 2021-05-05 2024-03-13 Immatics Biotechnologies GmbH Antigen binding proteins specifically binding prame
US12162940B2 (en) 2021-05-05 2024-12-10 Immatics Biotechnologies Gmbh BMA031 antigen binding polypeptides
AR130387A1 (es) * 2022-09-08 2024-12-04 Hoffmann La Roche Receptores de linfocitos t recombinantes
CN118146393A (zh) * 2022-11-07 2024-06-07 武汉波睿达生物科技有限公司 一种信号肽序列优化的靶向cd19的嵌合抗原受体及其应用
WO2024102954A1 (en) * 2022-11-10 2024-05-16 Massachusetts Institute Of Technology Activation induced clipping system (aics)
CN121358761A (zh) * 2023-01-05 2026-01-16 安吉勒斯治疗公司 用于基因转导及调控合成与免疫受体活性的方法和组合物
SE548109C2 (en) * 2023-03-28 2026-03-30 Cerimmune Therapeutics Ab Microglial endocytic receptors for use in the treatment of neurodegenerative disease
CA3278900A1 (en) * 2023-03-31 2024-10-03 AbelZeta Inc. BISPECIFIC CHIMERIC ANTIGENIC RECEPTORS TARGETING CD20 AND BCMA
CN121620592A (zh) * 2023-05-01 2026-03-06 西雅图儿童医院d/b/a西雅图儿童研究所 表达突变体白细胞介素15的免疫细胞
WO2024238962A1 (en) * 2023-05-18 2024-11-21 A2 Biotherapeutics, Inc. Immune cells with paired receptors and uses thereof
AU2024316791A1 (en) * 2023-07-28 2026-03-12 Nkilt Therapeutics, Inc. Chimeric ilt receptor compositions and methods
TW202513594A (zh) * 2023-09-28 2025-04-01 沛爾生技醫藥股份有限公司 具有自然殺手蛋白30跨膜結構域之核酸分子及包含其的嵌合抗原受體
WO2025193475A1 (en) * 2024-03-14 2025-09-18 The Regents Of The University Of California Enhancing immune cell innate and adaptive responses
WO2025194049A1 (en) * 2024-03-15 2025-09-18 Dana-Farber Cancer Institute, Inc. Engineered immune cells and methods of using the same
WO2025235862A1 (en) * 2024-05-10 2025-11-13 Inndura Therapeutics Inc. A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a
US20260015401A1 (en) * 2024-07-10 2026-01-15 Angeles Therapeutics, Inc. Compositions and methods comprising epitopes and polypeptides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350415A1 (en) * 1998-11-18 2000-05-25 Incyte Pharmaceuticals, Inc. Inflammation-associated genes
US20070124833A1 (en) * 2005-05-10 2007-05-31 Abad Mark S Genes and uses for plant improvement
US9833476B2 (en) * 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
KR102437522B1 (ko) * 2012-05-25 2022-08-26 셀렉티스 면역요법을 위한 동종이형 및 면역억제제 저항성인 t 세포의 조작 방법
US20150017136A1 (en) * 2013-07-15 2015-01-15 Cellectis Methods for engineering allogeneic and highly active t cell for immunotherapy
CN104769103B (zh) * 2012-09-04 2018-06-08 塞勒克提斯公司 多链嵌合抗原受体和其用途
WO2014039961A1 (en) * 2012-09-07 2014-03-13 University Of Miami Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
MX2015015638A (es) * 2013-05-13 2016-10-28 Cellectis Metodos para diseñar celulas t altamente activas para inmunoterapia.
PL3546572T3 (pl) * 2013-05-13 2024-07-22 Cellectis Chimeryczny receptor antygenowy swoisty względem cd19 i jego zastosowania
TWI750110B (zh) * 2014-07-21 2021-12-21 瑞士商諾華公司 使用人類化抗-bcma嵌合抗原受體治療癌症
IL287051B (en) * 2015-03-27 2022-09-01 Immunitybio Inc nk-2 cells and genetically engineered monoclonal antibodies for cancer treatment
EP4155411A1 (en) * 2016-02-23 2023-03-29 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
CN110352068A (zh) * 2016-12-02 2019-10-18 南加利福尼亚大学 合成的免疫受体及其使用方法
CN108728465A (zh) * 2017-04-14 2018-11-02 深圳新诺微环生物科技有限公司 一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
SG11202008568WA (en) * 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)
WO2020028656A1 (en) * 2018-08-01 2020-02-06 Nantkwest, Inc. A quadricistronic system comprising a homing receptor or a cytokine, and chimeric antigen receptor for genetic modification of immunotherapies

Similar Documents

Publication Publication Date Title
JPWO2022178367A5 (https=)
US20240390496A1 (en) Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
IL273201B1 (en) Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy
JPWO2021188599A5 (https=)
JP2020500530A5 (https=)
JP2021500861A5 (https=)
JP2025037871A5 (https=)
US11760806B2 (en) CD-38 directed chimeric antigen receptor constructs
JP2019518424A5 (https=)
JP2019525956A5 (https=)
CN113271953B (zh) 细胞免疫治疗的组合
JP2021532742A5 (https=)
JP2017513818A5 (https=)
IL297514A (en) Vectors and methods for in vivo transduction
EP4058561A1 (en) Engineered t cell receptors and uses thereof
RU2018122106A (ru) Буферы для стабилизации лентивирусных препаратов
WO2021030153A2 (en) Engineered t cell receptors and uses thereof
EP3728322A1 (en) Single- and multi-chain chimeric antigen receptors
WO2021030182A1 (en) Bifunctional single variable domain t cell receptors and uses thereof
JPWO2021071962A5 (https=)
CN110511912A (zh) 免疫细胞的功能调节
CN117683139A (zh) 组成型嵌合细胞因子受体及表达其的免疫细胞及应用
CN117202921A (zh) 用于多种免疫细胞的单链和多链合成抗原受体
JPWO2020020359A5 (https=)
JPWO2021258016A5 (https=)